Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 26, Issue 6, Pages 886-899
Publisher
Wiley
Online
2013-08-19
DOI
10.1111/pcmr.12156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Aurora Kinase B and Wee1-Like Protein Kinase as Downstream Targets of V600EB-RAF in Melanoma
- (2013) Arati Sharma et al. AMERICAN JOURNAL OF PATHOLOGY
- Cancers with increasing incidence trends in the United States: 1999 through 2008
- (2012) Edgar P. Simard et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Resistance patterns with tyrosine kinase inhibitors in melanoma
- (2012) Reinhard Dummer et al. CURRENT OPINION IN ONCOLOGY
- Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer
- (2012) R. Siobhan Darrington et al. INTERNATIONAL JOURNAL OF CANCER
- Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells
- (2012) Caroline Bonet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GSK3β Inhibition Blocks Melanoma Cell/Host Interactions by Downregulating N-Cadherin Expression and Decreasing FAK Phosphorylation
- (2012) Jobin K. John et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations
- (2012) J. G. Greger et al. MOLECULAR CANCER THERAPEUTICS
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting sphingosine kinase-1 to inhibit melanoma
- (2012) SubbaRao V. Madhunapantula et al. Pigment Cell & Melanoma Research
- The Akt Inhibitor ISC-4 Activates Prostate Apoptosis Response Protein-4 and Reduces Colon Tumor Growth in a Nude Mouse Model
- (2011) A. K. Sharma et al. CLINICAL CANCER RESEARCH
- Towards new therapeutic approaches for malignant melanoma
- (2011) Ivan Pacheco et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Inhibition of Glycogen Synthase Kinase-3 Increases the Cytotoxicity of Enzastaurin
- (2011) Mark A. Rovedo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Resistance to BRAF Inhibition in Melanomas
- (2011) David B. Solit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail
- (2010) Gajanan S. Inamdar et al. BIOCHEMICAL PHARMACOLOGY
- High-throughput RNAi screening to dissect cellular pathways: A how-to guide
- (2010) Christina Falschlehner et al. Biotechnology Journal
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Melanoma Chemoprevention in Skin Reconstructs and Mouse Xenografts Using Isoselenocyanate-4
- (2010) N. Nguyen et al. Cancer Prevention Research
- Akt3-Mediated Resistance to Apoptosis in B-RAF-Targeted Melanoma Cells
- (2010) Y. Shao et al. CANCER RESEARCH
- Glycogen Synthase Kinase-3 : A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer
- (2010) S. Naito et al. CLINICAL CANCER RESEARCH
- Vertical Inhibition of the mTORC1/mTORC2/PI3K Pathway Shows Synergistic Effects against Melanoma In Vitro and In Vivo
- (2010) Johannes Werzowa et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- KLF6 Gene and Early Melanoma Development in a Collagen I-Rich Extracellular Environment
- (2010) S. J. Huh et al. JNCI-Journal of the National Cancer Institute
- Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?
- (2010) Adi F. Gazdar et al. LUNG CANCER
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Multicentre study on standardisation of melanoma cell culture - an initiative of the German Melanoma Research Network
- (2010) J. Eberle et al. Pigment Cell & Melanoma Research
- Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy
- (2009) Shadi Mamaghani et al. BMC CANCER
- Glycogen synthase kinase 3: more than a namesake
- (2009) Geetha Vani Rayasam et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates
- (2009) A. Sharma et al. CLINICAL CANCER RESEARCH
- Identification and functional validation of therapeutic targets for malignant melanoma
- (2009) Gabriela Gremel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel
- (2009) Changxing Liu et al. JOURNAL OF CONTROLLED RELEASE
- Increasing Burden of Melanoma in the United States
- (2009) Eleni Linos et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Statistical methods for analysis of high-throughput RNA interference screens
- (2009) Amanda Birmingham et al. NATURE METHODS
- The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma
- (2009) SubbaRao V. Madhunapantula et al. Pigment Cell & Melanoma Research
- MEK1 mutations confer resistance to MEK and B-RAF inhibition
- (2009) C. M. Emery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization
- (2008) Elizabeth Iorns et al. BIOCHEMICAL JOURNAL
- Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
- (2008) Jia Luo CANCER LETTERS
- Targeting V600EB-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development
- (2008) M. A. Tran et al. CANCER RESEARCH
- Is B-Raf a Good Therapeutic Target for Melanoma and Other Malignancies?
- (2008) S. V. Madhunapantula et al. CANCER RESEARCH
- Maintenance of Constitutive I B Kinase Activity by Glycogen Synthase Kinase-3 / in Pancreatic Cancer
- (2008) W. Wilson et al. CANCER RESEARCH
- Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development
- (2008) M. Cheung et al. CANCER RESEARCH
- Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor- B, and Glucose Regulation
- (2008) S. Kotliarova et al. CANCER RESEARCH
- GSK3β inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes
- (2008) Barbara Bellei et al. CELLULAR SIGNALLING
- GSK3β: A master switch and a promising target
- (2008) Akanksha Kannoji et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Emerging therapies for melanoma
- (2008) Rajini Katipamula et al. Expert Review of Anticancer Therapy
- Unique and Overlapping Functions of GSK-3 Isoforms in Cell Differentiation and Proliferation and Cardiovascular Development
- (2008) Thomas Force et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PBISe, a novel selenium-containing drug for the treatment of malignant melanoma
- (2008) S. V. Madhunapantula et al. MOLECULAR CANCER THERAPEUTICS
- Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
- (2008) Zhong Wang et al. NATURE
- Genome-Wide siRNA-Based Functional Genomics of Pigmentation Identifies Novel Genes and Pathways That Impact Melanogenesis in Human Cells
- (2008) Anand K. Ganesan et al. PLoS Genetics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started